Povidone-iodine prevents growth of endophthalmitis bacterial isolates after cataract surgery

Article

Administering 5% povidone-iodine for 15 minutes or 10% povidone-iodine for 5 minuytes can contribute towards the prevention of the growth of endophthalmitis bacterial isolates.

Administering 5% povidone-iodine for 15 minutes or 10% povidone-iodine for 5 minutes can contribute towards the prevention of the growth of endophthalmitis bacterial isolates, asserts a study in the Journal of Cataract and Refractive Surgery.

Dr Hamid Hosseini et al., Poostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, performed an experimental study on 44 patients with postoperative endophthalmitis. Ocular-fluid samples were taken from all patients and evaluated by a microbiology laboratory. One millilitre of 1%, 2%, 5%, and 10% povidone-iodine solutions was combined with one millilitre of microbial isolate suspension. Each solution was transferred to appropriate culture media after 1 minute, 5 minutes and 15 minutes of exposure at 37°C.

Of the patients included in the study, organisms were isolated in 30. In 14 patients coagulase-negative Staphylococcus was identified, Streptococcus species in 8 patients, Staphylococcus aureus in 5 patients, Bacillus cereus in 2 patients and Pseudomonas aeruginosa in 1 patient.

The most effective concentration of solution was 5% povidone-iodine for 15 minutes and 10% povidone-iodine for 5 minutes. After long exposure with 10% povidone-iodine 13% of bacterial isolates remained.

The study advises the use of high concentrations of povidone-iodine with a long exposure time for the isolation of endophthalmitis bacteria post-cataract surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.